Douglas Blankenship
2017
In 2017, Douglas Blankenship earned a total compensation of $1.6M as Former Chief Financial Officer at Dova Pharmaceuticals.
Compensation breakdown
Option Awards | $1,357,551 |
---|---|
Salary | $208,526 |
Other | $1,042 |
Total | $1,567,119 |
Blankenship received $1.4M in option awards, accounting for 87% of the total pay in 2017.
Blankenship also received $208.5K in salary and $1K in other compensation.
Rankings
In 2017, Douglas Blankenship's compensation ranked 6,756th out of 14,666 executives tracked by ExecPay. In other words, Blankenship earned more than 53.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,756 | 54th |
Manufacturing | 2,503 | 57th |
Chemicals And Allied Products | 810 | 61st |
Drugs | 625 | 64th |
Pharmaceutical Preparations | 492 | 63rd |
Blankenship's colleagues
We found two more compensation records of executives who worked with Douglas Blankenship at Dova Pharmaceuticals in 2017.